Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

108.86
-2.0000-1.80%
Post-market: 108.860.00000.00%19:59 EDT
Volume:608.44K
Turnover:66.68M
Market Cap:5.36B
PE:-18.87
High:112.25
Open:110.18
Low:108.03
Close:110.86
Loading ...

Axsome Therapeutics price target raised to $150 from $110 at Leerink

TIPRANKS
·
11 Feb

Why Axsome Therapeutics Stock Is Skyrocketing Today

Motley Fool
·
11 Feb

Top Midday Gainers

MT Newswires Live
·
11 Feb

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

Benzinga
·
11 Feb

Axsome Therapeutics Price Target Maintained With a $133.00/Share by Needham

Dow Jones
·
11 Feb

Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday

Benzinga
·
10 Feb

Axsome Therapeutics Up Over 22%, on Track for Record High Close -- Data Talk

Dow Jones
·
10 Feb

Axsome Therapeutics Shares up 17.4% After Settlement Agreement With Teva for Depression Drug

THOMSON REUTERS
·
10 Feb

Axsome Therapeutics: Strategic Legal Resolution and Growth Potential Propel Buy Rating

TIPRANKS
·
10 Feb

Axsome Therapeutics Inc : TD Cowen Raises Target Price to $190 From $155

THOMSON REUTERS
·
10 Feb

Morning Movers: Aluminum, steel stocks gain on planned 25% tariffs on imports

TIPRANKS
·
10 Feb

Axsome Therapeutics Shares Rise After Agreement with Teva Pharmaceuticals Ends Litigation

Dow Jones
·
10 Feb

Axsome, Teva Settle Auvelity Patent Litigation

MT Newswires Live
·
10 Feb

BUZZ-Axsome Therapeutics rises on settlement with Teva for depression drug

Reuters
·
10 Feb

S&P 500 Futures Climb In Premarket Trading; Semtech, Brixmor Property Group Lag

Dow Jones
·
10 Feb

Axsome Therapeutics Inc - Settles Patent Litigation With Teva Over Auvelity

THOMSON REUTERS
·
10 Feb

Axsome Therapeutics Announces Settlement Agreement Resolving Auvelity® (Dextromethorphan Hbr – Bupropion Hcl) Patent Litigation

THOMSON REUTERS
·
10 Feb

Axsome Therapeutics Inc - All Ongoing Litigation Between Axsome and Teva to Be Terminated

THOMSON REUTERS
·
10 Feb

Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

GlobeNewswire
·
10 Feb

Truist Financial Sticks to Its Buy Rating for Axsome Therapeutics (AXSM)

TIPRANKS
·
07 Feb